Fate Therapeutics Inc (NASDAQ:FATE)

2.54
Delayed Data
As of Nov 28
 +0.25 / +10.96%
Today’s Change
1.63
Today|||52-Week Range
21.47
-74.83%
Year-to-Date

Today’s Trading

Previous close2.28
Today’s open2.27
Day’s range2.17 - 2.55
Volume1,731,066
Average volume (3 months)2,125,329
Market cap$232.7M
Data as of 3:59pm ET, 11/28/2023

Growth & Valuation

Earnings growth (last year)-29.95%
Earnings growth (this year)+36.20%
Earnings growth (next 5 years)+29.49%
Revenue growth (last year)+72.44%
P/E ratioNM
Price/Sales10.15
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
STOKStoke Therapeutics I...+0.01+0.25%
RAPTRAPT Therapeutics In...+0.43+3.11%
SNESSenestech Inc-0.95-50.53%
FWBIFirst Wave BioPharma...-0.01-2.38%
Data as of 3:59pm ET, 11/28/2023

Financials

Next reporting dateFebruary 27, 2024
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$96.3M
Annual profit (last year)-$281.7M
Net profit margin-292.55%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts